Winton Group’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Winton Group’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-183,748	Closed	-$663K	–	1565
2021 Q3	$663K	Buy	183,748 +9,516	+5%	+$35.9K	0.04%	711
2021 Q2	$624K	Buy	174,232 +22,652	+15%	+$79.9K	0.03%	795
2021 Q1	$593K	Buy	151,580 +10,738	+8%	+$44.3K	0.03%	786
2020 Q4	$592K	Sell	140,842 -203,997	-59%	-$786K	0.04%	701
2020 Q3	$1.29M	Sell	344,839 -52,840	-13%	-$225K	0.04%	704
2020 Q2	$1.73M	Buy	397,679 +125,279	+46%	+$563K	0.04%	717
2020 Q1	$1.03M	Sell	272,400 -118,312	-30%	-$581K	0.03%	795
2019 Q4	$2.47M	Buy	390,712 +32,594	+9%	+$192K	0.03%	721
2019 Q3	$1.51M	Buy	+358,118	New	+$1.53M	0.02%	673

Other funds holding BDSI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Winton Group's BDSI Position: Q4 2021 in Review

Winton Group sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2021, closing a stake of 183,748 shares — an estimated $663K sold.

Winton Group first reported a position in BDSI in Q3 2019 and held it in 9 quarters. The position peaked at $2.47M in Q4 2019. 156 funds tracked by Wall St. Rank hold BDSI as of Q4 2021.

Winton Group reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2021 after selling out during the quarter.
Winton Group sold 183,748 BioDelivery Sciences International, Inc. shares in Q4 2021, an estimated $663K.
Winton Group first reported a position in BioDelivery Sciences International, Inc. in Q3 2019 and held it in 9 quarters.
Winton Group's BioDelivery Sciences International, Inc. position peaked at $2.47M in Q4 2019.
156 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2021.

Based on Winton Group's 13F filing for Q4 2021, filed 10 Feb 2022.